KKR to Return Over $40B | I-RES at Asset Value | Surgery Partners Closed Above $25

$40 billion.

KKR (KKR) expects to return more than that to its clients this year. Its co-chief executives said it is selling holdings and paying clients back at record levels. On Sunday, PMD said sales near the pace of Carlyle (CG) would show exits are opening. Spread evenly, $40 billion is about $10 billion a quarter, by PMD's math. Carlyle's funds realized about $9 billion last quarter. The two measures differ, but the pace is similar.

Cash is going back to clients at a record rate, even as assets missed forecasts.

• Stocks rebounded. The S&P 500 closed up about 2.4%, the Nasdaq about 2.7% and the Russell 2000 about 3.1%. Nvidia (NVDA) fell about 4% in its first full session since its board opened an independent investigation. A chip-stock fund rose about 5%. The board has said it has no reason to believe national security or Nvidia secrets were compromised.
• Brent fell more than 5%, to near $93. Treasury yields still edged up. Two regional Fed presidents pointed to service prices and to costs that firms are passing on.
• October consumer prices land Tuesday. Traders price a December rate hike at roughly 75% to 80%.
• Constellation Energy (CEG) gained about 10% after it beat forecasts and raised the midpoint of its outlook. CoreWeave (CRWV) reports Tuesday after the close. Its stock rose about 6% Monday, but the cost to insure its debt is up 50% in a month, a report said.

KKR Earned a Record and Sees Over $40 Billion Going Back to Clients. Its Assets Came In Below Forecasts.

KKR earned a record $1.78 a share on an adjusted basis. Analysts expected $1.58. Fee-related earnings rose 27%, to about $1.3 billion. Adjusted earnings add gains from sales and the insurance arm's operating profit to those fees.

Assets under management rose 11%, to $804 billion. Analysts expected about $817 billion. KKR raised $25 billion of new capital in the quarter.

Reported revenue fell to $4.56 billion from $5.53 billion. Insurance revenue fell to $2.80 billion from $3.78 billion, slightly more than the whole drop.

KKR's shares rose about 1.7%, less than the S&P 500's 2.4%.

Payouts Hit a Record. Assets Missed Forecasts.

Holders may have cared more about the asset miss than the record profit. Or they may be waiting to see whether open exits turn into bigger funds. KKR's fundraising and sales next quarter will show which.

SIGNAL 1: Barings Made Its I-RES Offer Firm a Day Early. The Price Equals I-RES's Reported Asset Value.

This morning, PMD said no firm offer had been made for I-RES, a listed Irish landlord. Barings made one Monday, a day before its deadline. The board recommends it. The offer is worth €1.386 a share, in cash plus a small dividend. That values I-RES at about €731 million.

The offer equals the net tangible assets per share I-RES last reported. It is 30.8% above the share price before the approach. Back then, the stock traded 23.5% below those assets. Holders get the full reported value in cash and nothing above it. Barings funds supply the equity, alongside debt of undisclosed size.

WHAT RESOLVES THIS

The scheme document, expected around Dec. 7, and the holder vote. The deal is expected to take effect in the first quarter of 2027.

SIGNAL 2: Surgery Partners Took $25 Over a $28 Proposal. Its Stock Closed Above $25.

Surgery Partners (SGRY) agreed to a raised $25 cash price, up from $23.50. The buyer is HealthSpan Partners, an affiliate of Bon Secours Mercy Health. An unnamed party had proposed $28 in cash, but not as a binding offer. The board's special committee found it was not a superior proposal. It cited a longer or less certain closing, regulatory risk and missing contract protections.

The $25 can grow. A fee starts if holders approve but the deal has not closed by March 1, 2027. It builds at 10% a year, up to $1.61. That caps the payout at $26.61. The stock ended near $26.45, up about 14% and just under that cap. Traders may see a chance of a higher bid. Or they may expect a slower close than the company does, which would pay out most of the fee. The stock alone cannot say which.

WHAT RESOLVES THIS

The proxy and a Schedule 13E-3 filing, which will show how the $28 proposal came about. Or a firm offer, a higher bid or a withdrawal from the other party.

SIGNAL 3: Strategy Spent 2.3 Times as Much on Its Preferred as on Bitcoin. Bitcoin Stayed Below Strategy's Average Cost.

Strategy (MSTR) bought 1,036 bitcoin for $81.9 million in the week through Sunday, its weekly filing showed. It spent $188.3 million buying back its STRC preferred stock. It paid for both by selling $283.8 million of common stock. The week before, it also spent more on the preferred than on bitcoin.

This morning, PMD noted that bitcoin had fallen below Strategy's average cost of $75,456 a coin. Late Monday, bitcoin was still just under $75,000. Strategy holds 850,364 bitcoin. The shortfall is on paper only, and management has said no covenants are tied to that average. Strategy shares fell about 2.6%.

WHAT RESOLVES THIS

MSCI is due Wednesday to name the companies its new index rules will remove, and Strategy could be one. Next Monday's filing will show if the preferred still gets the larger share.

• Polymarket's contract on Jensen Huang's resignation or removal by Dec. 31 stayed between about 13 and 15.5 cents through the afternoon. It barely moved as Nvidia's stock fell.
• The New York Fed's October survey put households' odds of higher unemployment in a year at 45.3%. That is the highest since April 2020.
• Sequoia said last week it removed "much of the complexity" from the evergreen fund it began in 2021. A report said the fund was largely unwound after some backers objected to limits on withdrawals.

Private Market Trends Driving Public Market Moves

Getting cash out now sets the terms.

Backers want their cash back, and sellers are taking known prices to deliver it. That can close the gap between a stock and its asset value with nothing paid above it. Holders who wanted more give up that upside, and some still bet a deal can improve. For managers, payouts help only if new commitments keep up. A firm rival bid, or KKR's fundraising in the coming quarter, would show whether this holds.

On the calendar...